Barclays PLC Fulgent Genetics, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Barclays PLC holds 174,855 shares of FLGT stock, worth $3.52 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

174,855

Previous 174,855 -0.0%

Holding current value

$3.52 Million

Previous $3.8 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$19.6 - $25.06 $632,100 - $808,185	32,250 Added 22.61%	174,855 $3.8 Million
Q2 2024 Aug 14, 2024	SELL	$19.09 - $22.57 $162,952 - $192,657	-8,536 Reduced 5.65%	142,605 $2.8 Million
Q1 2024 May 15, 2024	BUY	$21.55 - $29.29 $2.19 Million - $2.98 Million	101,607 Added 205.13%	151,141 $3.28 Million
Q4 2023 Feb 15, 2024	BUY	$23.64 - $30.27 $848,770 - $1.09 Million	35,904 Added 263.42%	49,534 $1.43 Million
Q3 2023 Nov 07, 2023	BUY	$26.74 - $40.81 $24,333 - $37,137	910 Added 7.15%	13,630 $365,000
Q2 2023 Aug 03, 2023	SELL	$28.52 - $40.7 $25,867 - $36,914	-907 Reduced 6.66%	12,720 $472,000
Q1 2023 May 04, 2023	BUY	$29.39 - $36.27 $110,653 - $136,556	3,765 Added 38.18%	13,627 $426,000
Q4 2022 Feb 13, 2023	BUY	$29.23 - $40.28 $133,054 - $183,354	4,552 Added 85.73%	9,862 $293,000
Q3 2022 Nov 03, 2022	SELL	$37.92 - $63.74 $207,612 - $348,976	-5,475 Reduced 50.76%	5,310 $203,000
Q2 2022 Aug 12, 2022	SELL	$47.98 - $62.75 $443,958 - $580,625	-9,253 Reduced 46.18%	10,785 $589,000
Q1 2022 May 16, 2022	SELL	$49.85 - $96.11 $430,803 - $830,582	-8,642 Reduced 30.13%	20,038 $1.25 Million
Q4 2021 Feb 14, 2022	BUY	$77.3 - $105.0 $648,778 - $881,265	8,393 Added 41.37%	28,680 $2.89 Million
Q3 2021 Nov 09, 2021	BUY	$74.87 - $110.87 $593,269 - $878,533	7,924 Added 64.09%	20,287 $1.83 Million
Q2 2021 Aug 13, 2021	SELL	$66.8 - $100.45 $415,228 - $624,397	-6,216 Reduced 33.46%	12,363 $1.14 Million
Q1 2021 May 13, 2021	BUY	$59.3 - $183.85 $231,863 - $718,853	3,910 Added 26.65%	18,579 $1.79 Million
Q4 2020 Feb 11, 2021	BUY	$31.01 - $52.1 $37,336 - $62,728	1,204 Added 8.94%	14,669 $764,000
Q3 2020 Nov 12, 2020	BUY	$15.89 - $50.51 $128,963 - $409,939	8,116 Added 151.73%	13,465 $540,000
Q2 2020 Aug 12, 2020	BUY	$8.89 - $18.28 $47,552 - $97,779	5,349 New	5,349 $85,000

Others Institutions Holding FLGT

# of Institutions

201

Shares Held

16.1M

Call Options Held

2.04M

Put Options Held

14K

View Full List

About Fulgent Genetics, Inc.

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

More about FLGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account